Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

EVOLVING EPIDEMIOLOGY OF HIV AND SARS-CoV-2

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 12 of 12
INTRODUCTION OF SPEAKERS PART I
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
ESTIMATING THE LIFETIME RISK OF A DIAGNOSIS OF HIV INFECTION IN THE UNITED STATES   (ABSTRACT 43)
Sonia Singh
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
LARGE HIV CLUSTERS AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES   (ABSTRACT 44)
Stephen Perez
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
HIV-1 DIAGNOSES IN NORTH CAROLINA, 2018-21: INCIDENT INFECTIONS AND DRUG RESISTANCE   (ABSTRACT 45)
Shuntai Zhou
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
SARS-COV-2 PREVALENCE IN CHILDREN AND ADULTS IN 15 US COMMUNITIES: THE COMPASS STUDY   (ABSTRACT 46)
Jessica E Justman
Columbia University, New York, NY, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Jessica E Justman
Columbia University, New York, NY, USA
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
Stephen Perez
Centers for Disease Control and Prevention, Atlanta, GA, USA
Sonia Singh
Centers for Disease Control and Prevention, Atlanta, GA, USA
Shuntai Zhou
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
INTRODUCTION OF SPEAKERS PART II
James A McIntyre
Anova Health Institute, Johannesburg, Gauteng, South Africa
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
SAFETY AND EFFECTIVENESS OF THE AD26.COV2.S VACCINE IN SOUTH AFRICA   (ABSTRACT 47)
Glenda E Gray
South African Medical Research Council, Cape Town, South Africa
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION   (ABSTRACT 48)
Jing Sun
Johns Hopkins University, Baltimore, MD, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
INFECTIOUSNESS OF BREAKTHROUGH INFECTIONS AFTER VACCINATION AND NATURAL INFECTION   (ABSTRACT 49)
Laith J Abu-Raddad
Weill Cornell Medicine-Qatar, Doha, Qatar
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
COVID-19 VACCINATION RATES IN A GLOBAL HIV COHORT   (ABSTRACT 50)
Evelynne S Fulda
Massachusetts General Hospital, Boston, MA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART II
Laith J Abu-Raddad
Weill Cornell Medicine-Qatar, Doha, Qatar
James A McIntyre
Anova Health Institute, Johannesburg, Gauteng, South Africa
Evelynne S Fulda
Massachusetts General Hospital, Boston, MA, USA
Glenda E Gray
South African Medical Research Council, Cape Town, South Africa
Jing Sun
Johns Hopkins University, Baltimore, MD, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 12 of 12